 | • レポートコード：MRC2305A122 • 出版社/出版日：Transparency Market Research / 2023年3月9日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：バイオ |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界の幹細胞製造市場規模が、2023年の102億ドルから2031年には266億ドルまで年平均9.2%成長すると見込まれています。本資料は幹細胞製造の世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、製品別（消耗品、器具、幹細胞株）分析、用途別（研究、臨床、細胞&組織バンク）分析、エンドユーザー別（製薬&バイオテクノロジー、学術研究機関、研究所&CRO、病院&外科センター、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、Thermo Fisher Scientific、Merck Millipore、Lonza Group AG、Danaher Corporation、Sartorius AG、Bio-Rad Laboratories、Becton, Dickinson and Company、Stemcell Technologies、Fujifilm Holdings Corporation、Miltenyi Biotech、Terumo Corporation、Corning Inc.、Bio-Techno Corporation、Takara Bio Group、Eppendorf AGなどの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界の幹細胞製造市場規模：製品別 - 消耗品の市場規模 - 器具の市場規模 - 幹細胞株の市場規模 ・世界の幹細胞製造市場規模：用途別 - 研究における市場規模 - 臨床における市場規模 - 細胞&組織バンクにおける市場規模 ・世界の幹細胞製造市場規模：エンドユーザー別 - 製薬&バイオテクノロジーにおける市場規模 - 学術研究機関における市場規模 - 研究所&CROにおける市場規模 - 病院&外科センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の幹細胞製造市場規模：地域別 - 北米の幹細胞製造市場規模 - 中南米の幹細胞製造市場規模 - ヨーロッパの幹細胞製造市場規模 - アジア太平洋の幹細胞製造市場規模 - 中東・アフリカの幹細胞製造市場規模 ・競争状況 ・企業情報 ・主要ポイント |
Stem Cell Manufacturing Market – Scope of Report
TMR’s report on the global stem cell manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global stem cell manufacturing market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stem cell manufacturing market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the stem cell manufacturing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stem cell manufacturing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stem cell manufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stem cell manufacturing market.
The report delves into the competitive landscape of the global stem cell manufacturing market. Key players operating in the global stem cell manufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stem cell manufacturing market profiled in this report.
Key Questions Answered in Global Stem Cell Manufacturing Market Report
• What is the sales/revenue generated by stem cell manufacturing across all regions during the forecast period?
• What are the opportunities in the global stem cell manufacturing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Stem Cell Manufacturing Market – Research Objectives and Research Approach
The comprehensive report on the global stem cell manufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global stem cell manufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stem cell manufacturing market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
5.3.1. Consumables
5.3.1.1. Culture Media
5.3.1.2. Other Consumables
5.3.2. Hematopoietic Stem Cells
5.3.2.1. Mesenchymal Stem Cells
5.3.2.2. Induced Pluripotent Stem Cells
5.3.2.3. Embryonic Stem Cells
5.3.2.4. Neural Stem Cells
5.3.2.5. Multipotent Adult Progenitor Stem Cells
5.3.3. Instruments
5.3.3.1. Bioreactor and Incubator
5.3.3.2. Cell Sorter
5.3.3.3. Other Instruments
5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033
6.3.1. Research Applications
6.3.1.1. Life Science Research
6.3.1.2. Drug Discovery and Development
6.3.2. Clinical Application
6.3.2.1. Allogenic Stem Cell Therapy
6.3.2.2. Autologous Stem Cell Therapy
6.3.3. Cell & Tissue Banking
6.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
6.5. Absolute $ Opportunity Analysis By Application, 2023-2033
7. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
7.3.1. Pharmaceutical & Biotechnology Companies
7.3.2. Academic Institutes, Research Laboratories & CROs
7.3.3. Hospital & Surgical Centers
7.3.4. Cell & Tissue Banks
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
7.5. Absolute $ Opportunity Analysis By End User, 2023-2033
8. Global Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. U.K.
11.2.1.2. Spain
11.2.1.3. Germany
11.2.1.4. Italy
11.2.1.5. France
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Rest of Asia Pacific
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. Middle East and Africa Stem Cell Manufacturing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. South Africa
13.2.1.2. GCC Countries
13.2.1.3. Rest of Middle East and Africa
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Stem Cell Manufacturing Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product
14.1.2.2. By Application
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product
14.2.2.2. By Application
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product
14.3.2.2. By Application
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product
14.4.2.2. By Application
14.4.2.3. By End User
14.5. U.K.
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product
14.5.2.2. By Application
14.5.2.3. By End User
14.6. Spain
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product
14.6.2.2. By Application
14.6.2.3. By End User
14.7. Germany
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product
14.7.2.2. By Application
14.7.2.3. By End User
14.8. Italy
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product
14.8.2.2. By Application
14.8.2.3. By End User
14.9. France
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product
14.9.2.2. By Application
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product
14.10.2.2. By Application
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product
14.11.2.2. By Application
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product
14.12.2.2. By Application
14.12.2.3. By End User
14.13. South Africa
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product
14.13.2.2. By Application
14.13.2.3. By End User
14.14. GCC Countries
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product
14.14.2.2. By Application
14.14.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Thermo Fisher Scientific
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Merck Millipore
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Lonza Group AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Danaher Corporation
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Sartorius AG
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Bio-Rad Laboratories
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Becton, Dickinson and Company
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Stemcell Technologies
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Fujifilm Holdings Corporation
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Miltenyi Biotech
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.11. Terumo Corporation
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.12. Corning Inc.
16.1.12.1. Overview
16.1.12.2. Product Portfolio
16.1.12.3. Profitability by Market Segments
16.1.12.4. Sales Footprint
16.1.12.5. Strategy Overview
16.1.12.5.1. Marketing Strategy
16.1.13. Bio-Techno Corporation
16.1.13.1. Overview
16.1.13.2. Product Portfolio
16.1.13.3. Profitability by Market Segments
16.1.13.4. Sales Footprint
16.1.13.5. Strategy Overview
16.1.13.5.1. Marketing Strategy
16.1.14. Takara Bio Group
16.1.14.1. Overview
16.1.14.2. Product Portfolio
16.1.14.3. Profitability by Market Segments
16.1.14.4. Sales Footprint
16.1.14.5. Strategy Overview
16.1.14.5.1. Marketing Strategy
16.1.15. Eppendorf AG
16.1.15.1. Overview
16.1.15.2. Product Portfolio
16.1.15.3. Profitability by Market Segments
16.1.15.4. Sales Footprint
16.1.15.5. Strategy Overview
16.1.15.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology